| Stage | CRI | % of rev | PRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $752M | 100.00% | $726M | 100.00% | CRI ×1.04 |
| Gross profit | $355M | 47.15% | $619M | 85.35% | PRG +38.2pp |
| Operating income | $56M | 7.41% | $66M | 9.09% | PRG +1.7pp |
| Pre-tax income | $48M | 6.43% | $52M | 7.21% | PRG +0.8pp |
| Net income | $37M | 4.87% | $37M | 5.13% | PRG +0.3pp |
| Stage | CRI | PRG | Gap · A − B |
|---|---|---|---|
| Revenue | $752M100.00% | $726M100.00% | CRI ×1.04 |
| Gross profit | 47.15%$355M | 85.35%$619M | PRG +38.2pp |
| Operating income | 7.41%$56M | 9.09%$66M | PRG +1.7pp |
| Pre-tax income | 6.43%$48M | 7.21%$52M | PRG +0.8pp |
| Net income |
| 4.87%$37M |
| 5.13%$37M |
| PRG +0.3pp |
No shared counterparties.